Item 1. Financial Statements
Item 1. Financial Statements
SEMILEDS CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands of U.S. dollars and shares, except par value)
November 30,
August 31,
2020
2020
(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$
2,693
$
2,832
Restricted cash and cash equivalents
87
85
Accounts receivable (including related parties), net of allowance for doubtful accounts of $192 and $187 as of November 30, 2020 and August 31, 2020, respectively
594
1,331
Inventories
2,765
2,476
Prepaid expenses and other current assets
750
781
Total current assets
6,889
7,505
Property, plant and equipment, net
5,621
5,645
Operating lease right of use assets
168
203
Intangible assets, net
88
89
Investments in unconsolidated entities
974
952
Other assets
194
186
TOTAL ASSETS
$
13,934
$
14,580
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current installments of long-term debt
$
4,884
$
4,750
Accounts payable
424
536
Advance receipt toward the convertible note
500
500
Accrued expenses and other current liabilities
2,728
2,654
Other payable to related parties
536
460
Operating lease liabilities, current portion
77
97
Total current liabilities
9,149
8,997
Long-term debt, excluding current installments
2,852
2,909
Operating lease liabilities, less current portion
91
106
Total liabilities
12,092
12,012
Commitments and contingencies (Note 6)
EQUITY:
SemiLEDs stockholders’ equity
Common stock, $0.0000056 par value—7,500 shares authorized; 4,011 shares issued and outstanding as of both November 30, 2020 and August 31, 2020
—
—
Additional paid-in capital
177,247
177,235
Accumulated other comprehensive income
3,618
3,647
Accumulated deficit
(179,057
)
(178,360
)
Total SemiLEDs stockholders' equity
1,808
2,522
Noncontrolling interests
34
46
Total equity
1,842
2,568
TOTAL LIABILITIES AND EQUITY
$
13,934
$
14,580
See notes to unaudited condensed consolidated financial statements.
1
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations
(In thousands of U.S. dollars and shares, except per share data)
Three Months Ended November 30,
2020
2019
Revenues, net
$
719
$
1,563
Cost of revenues
741
1,045
Gross profit (loss)
(22
)
518
Operating expenses:
Research and development
346
430
Selling, general and administrative
681
726
Gain on disposals of long-lived assets
(77
)
(79
)
Total operating expenses
950
1,077
Loss from operations
(972
)
(559
)
Other income (expenses):
Interest expenses, net
(92
)
(78
)
Other income, net
170
157
Foreign currency transaction gain, net
187
158
Total other income, net
265
237
Loss before income taxes
(707
)
(322
)
Income tax expense
—
—
Net loss
(707
)
(322
)
Less: Net loss attributable to noncontrolling interests
(10
)
(5
)
Net loss attributable to SemiLEDs stockholders
$
(697
)
$
(317
)
Net loss per share attributable to SemiLEDs stockholders:
Basic and diluted
$
(0.17
)
$
(0.09
)
Shares used in computing net loss per share attributable to SemiLEDs stockholders:
Basic and diluted
4,013
3,595
See notes to unaudited condensed consolidated financial statements.
2
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Comprehensive Loss
(In thousands of U.S. dollars)
Three Months Ended November 30,
2020
2019
Net loss
$
(707
)
$
(322
)
Other comprehensive gain (loss), net of tax:
Foreign currency translation adjustments, net of tax of $0 for both periods
(28
)
(23
)
Comprehensive loss
(735
)
(345
)
Comprehensive loss attributable to noncontrolling interests
(9
)
(4
)
Comprehensive loss attributable to SemiLEDs stockholders
$
(726
)
$
(341
)
See notes to unaudited condensed consolidated financial statements.
3
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Changes in Equity
(In thousands of U.S. dollars and shares)
Accumulated
Total
Additional
Other
SemiLEDs
Non-
Common Stock
Paid-in
Comprehensive
Accumulated
Shareholders'
Controlling
Total
Shares
Amount
Capital
Income
Deficit
Equity
Interests
Equity
BALANCE at September 1, 2020
4,011
$
—
$
177,235
$
3,647
$
(178,360
)
$
2,522
$
46
$
2,568
Stock-based compensation
—
—
21
—
—
21
—
21
Change ownership in SBDI*
—
—
(9
)
—
—
(9
)
(3
)
(12
)
Comprehensive loss:
Other comprehensive income (loss)
—
—
—
(29
)
—
(29
)
1
(28
)
Net loss
—
—
—
—
(697
)
(697
)
(10
)
(707
)
BALANCE at November 30, 2020
4,011
$
—
$
177,247
$
3,618
$
(179,057
)
$
1,808
$
34
$
1,842
Accumulated
Total
Additional
Other
SemiLEDs
Non-
Common Stock
Paid-in
Comprehensive
Accumulated
Shareholders'
Controlling
Total
Shares
Amount
Capital
Income
Deficit
Equity
Interests
Equity
BALANCE at September 1, 2019
3,594
$
—
$
175,804
$
3,753
$
(177,816
)
$
1,741
$
47
$
1,788
Issuance of common stock under equity incentive plans
1
—
—
—
—
—
—
—
Stock-based compensation
—
—
35
—
—
35
—
35
Comprehensive loss:
—
—
Other comprehensive income (loss)
—
—
—
(24
)
—
(24
)
1
(23
)
Net loss
—
—
—
—
(317
)
(317
)
(5
)
(322
)
BALANCE at November 30, 2019
3,595
$
—
$
175,839
$
3,729
$
(178,133
)
$
1,435
$
43
$
1,478
See notes to unaudited condensed consolidated financial statements.
*SBDI (Taiwan Bandaoti Zhaoming Co., Ltd.) is one of the Company’s subsidiaries.
4
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Cash Flows
(In thousands of U.S. dollars)
Three Months Ended November 30,
2020
2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
$
(707
)
$
(322
)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
215
207
Stock-based compensation expense
21
35
Provisions for inventory write-downs
196
119
Gain on disposals of long-lived assets
(77
)
(79
)
Changes in :
Accounts receivable
987
(6
)
Inventories
(427
)
(293
)
Prepaid expenses and other assets
48
34
Accounts payable
(138
)
(91
)
Accrued expenses and other current liabilities
(30
)
72
Net cash provided by (used in) operating activities
88
(324
)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment
(41
)
(50
)
Proceeds from sales of property, plant and equipment
77
79
Payments for development of intangible assets
(6
)
(8
)
Net cash provided by investing activities
30
21
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of long-term debt
—
(103
)
Acquisition of noncontrolling interests
(12
)
—
Net cash used in financing activities
(12
)
(103
)
Change in cash balances included in current assets held for sale
—
(61
)
Effect of exchange rate changes on cash and cash equivalents
(241
)
(143
)
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
(135
)
(610
)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period
3,012
1,471
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH—End of period
$
2,877
$
861
NONCASH INVESTING AND FINANCING ACTIVITIES:
Accrual related to property, plant and equipment
$
22
$
97
See notes to unaudited condensed consolidated financial statements.
5
SEMILEDS CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(UNAUDITED)
1. Business
SemiLEDs Corporation (“SemiLEDs” or the “parent company”) was incorporated in Delaware on January 4, 2005 and is a holding company for various wholly owned subsidiaries. SemiLEDs and its subsidiaries (collectively, the “Company”) develop, manufacture and sell high performance light emitting diodes (“LEDs”). The Company’s core products are LED components, as well as LED chips and lighting products. LED components have become the most important part of its business. A portion of the Company’s business consists of the sale of contract manufactured LED products. The Company’s customers are concentrated in a few select markets, including Taiwan, the United States, Germany and India.
As of November 30, 2020, SemiLEDs had two wholly owned subsidiaries. SemiLEDs Optoelectronics Co., Ltd., or Taiwan SemiLEDs, is the Company’s wholly owned operating subsidiary, where a substantial portion of the assets is held and located, and where a portion of our research, development, manufacturing and sales activities take place. Taiwan SemiLEDs owns a 97% equity interest in Taiwan Bandaoti Zhaoming Co., Ltd., formerly known as Silicon Base Development, Inc., which is engaged in the research, development, manufacturing and a substantial portion of marketing and sale of LED components, and where most of the Company’s employees are based. On November 27, 2019, SemiLEDs entered into a stock purchase agreement (the “Agreement”) with XianChang Ma (the “Purchaser”) pursuant to which the Purchaser agreed to purchase all of the outstanding shares of the Company’s Hong Kong subsidiary, Semileds International Corporation Limited, and its wholly owned subsidiary Xuhe Guangdian Co Ltd. for $100,000 and an additional $40,000 for the transaction costs. The Purchaser paid $140,000 to the Company, and the transaction was completed in January 2020. The Purchaser also subscribed for approximately 4% of the Company’s outstanding common shares on January 17, 2020 (see Note 7).
SemiLEDs’ common stock trades on the NASDAQ Capital Market under the symbol “LEDS”.
2. Summary of Significant Accounting Policies
Basis of Presentation —The Company’s unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable provisions of the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the rules and regulations of the SEC. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the SEC on November 17, 2020. The unaudited condensed consolidated balance sheet as of August 31, 2020 included herein was derived from the audited consolidated financial statements as of that date.
The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of the Company’s unaudited condensed consolidated balance sheet as of November 30, 2020, the unaudited condensed statements of operations and comprehensive loss for the three months ended November 30, 2020 and 2019, changes in equity for the three months ended November 30, 2020, and cash flows for the three months ended November 30, 2020 and 2019. The results for the three months ended November 30, 2020 are not necessarily indicative of the results to be expected for the year ending August 31, 2021.
Going Concern —The accompanying unaudited interim condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The realization of assets and the satisfaction of liabilities in the normal course of business are dependent on, among other things, the Company’s ability to operate profitably, to generate cash flows from operations, and to pursue financing arrangements to support its working capital requirements.
6
The Company s uffered losses from operations of $ 2.1 million and $ 3.7 million, and used net cash in operating activities of $ 1.0 million and $ 3.5 million for the years ended August 31, 20 20 and 201 9 , respectively. These facts and conditions have raised substantial doubt about the Company’s ability to continue as a going concern, even though gross profit on product sales was $ 1.6 million fo r the year ended August 31, 20 20 compared to $ 452 thousand fo r the year ended August 31, 201 9 . On November 30, 2020, the Company’s cash and cash equivalents had increased to $ 2.7 million compared to $ 688 thousand on November 30, 2019, mainly due to the issuance of convertible notes and common stock in private placement s . Further, l oss from operations and net cash provided by operating activities for the thre e months ended November 30, 20 20 were $ 972 thousand and $ 88 thousand , respectivel y. However, Management believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, should provide sufficient liquidity to meet the Company’s obligations as they become due for a reasonable period of time, and allow the development of its core business.
•
Gaining positive cash-inflow from operating activities through continuous cost reductions and the sales of new higher margin products. Steady growth of module products and the continued commercial sales of its UV LED product are expected to improve the Company’s future gross margin, operating results and cash flows. The Company is targeting niche markets and focused on product enhancement and developing its LED product into many other applications or devices.
•
Continuing to monitor prices, work with current and potential vendors to decrease costs and, consistent with its existing contractual commitments, may possibly decrease its activity level and capital expenditures further. This plan reflects its strategy of controlling capital costs and maintaining financial flexibility.
•
Raising additional cash through further equity offerings, sales of assets and/or issuance of debt as considered necessary and looking at other potential business opportunities.
While the Company's management believes that the measures described in the above liquidity plan will be adequate to satisfy its liquidity requirements for the twelve months after the date that the financial statements are issued, there is no assurance that the liquidity plan will be successfully implemented. Failure to successfully implement the liquidity plan may have a material adverse effect on its business, results of operations and financial position, and may adversely affect its ability to continue as a going concern. These unaudited interim condensed consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.
Restricted Cash Equivalents —Restricted cash primarily consists of cash held in reserved bank accounts in Taiwan. As of November 30, 2020 and August 31, 2020, the Company’s restricted cash equivalents at current portion amounted $87 thousand and $85 thousand, respectively. As of November 30, 2020 and August 31, 2020, the Company’s restricted cash at noncurrent portion, which was recorded as other assets, amounted to $97 thousand and $95 thousand, respectively.
Revenue Recognition —Effective September 1 2018, the Company adopted ASC 606 using the modified retrospective transition method. The Company applied the following five steps to achieve the core principles of ASC 606: 1) identified the contract with a customer; 2) identified the performance obligations (promises) in the contract; 3) determined the transaction price; 4) allocated the transaction price to the performance obligations in the contract; and 5) recognized revenue when (or as) the Company satisfies a performance obligation. The Company recognizes the amount of revenue, when the Company satisfies a performance obligation, to which it expects to be entitled for the transfer of promised goods or services to customers. The Company obtains written purchase authorizations from its customers as evidence of an arrangement and these authorizations generally provide for a specified amount of product at a fixed price. Generally, the Company considers delivery to have occurred at the time of shipment as this is generally when title and risk of loss for the products will pass to the customer. The Company provides its customers with limited rights of return for non‑conforming shipments and product warranty claims. Based on historical return percentages, which have not been material to date, and other relevant factors, the Company estimates its potential future exposure on recorded product sales, which reduces product revenues in the consolidated statements of operations and reduces accounts receivable in the consolidated balance sheets. The Company also provides standard product warranties on its products, which generally range from three months to two years. Management estimates the Company’s warranty obligations as a percentage of revenues, based on historical knowledge of warranty costs and other relevant factors. To date, the related estimated warranty provisions have been insignificant.
Principles of Consolidation —The unaudited interim condensed consolidated financial statements include the accounts of SemiLEDs and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated during consolidation.
On September 1, 2018, the Company adopted ASC 825-10, “Financial Instruments- Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”. This standard allows equity investments that do not have readily determinable fair values to be re-measured at fair value either upon the occurrence of an observable price change or upon identification of impairment. The standard also simplifies the impairment assessment of equity investments without readily determinable fair values by requiring assessment for impairment qualitatively at each reporting period.
7
Investments in which the Company has the ability to exercise significant influence over the investee but not a controlling financial interest, are accounted for using the equity method of accounting and are not consolidated. These investments are in joint ventures that are not subject to consolidation under the variable interest model, and for which the Company: (i) does not have a majority voting interest that would allow it to control the investee, or (ii) has a majority voting interest but for which other shareholders have significant participating rights, but for which the Company has the ability to exercise significant influence over operating and financial policies. Under the equity method, investments are stated at cost after adding or removing the Company’s portion of equity in undistributed earnings or losses, respectively. The Company’s investment in these equity ‑ method entities is reported in the consolidated balance sheets in investments in unconsolidated entities, and the Company’s share of the income or loss of these equity ‑ method entities, after the elimination of unrealized intercompany profits, is reported in the consolidated statements of operations in equity in losses from unconsolidated entities. When net losses from an equity ‑ method investee exceed its carrying amount, the carrying amount of the investment is reduced to zero. The Company then suspends using the equity method to provide for additional losses unless the Company has guaranteed obligations or is otherwise committed to provide further financial support to the equity ‑ method investee. The Company resumes accounting for the investment under the equity method if the investee subsequently returns to profitability and the Company’s share of the investee’s income exceeds its share of the cumulative losses that have not been previously recognized during the period the equity method is suspended.
Investments in entities that are not consolidated or accounted for under the equity method are recorded as investments without readily determinable fair values. Investments without readily determinable fair values are reported on the consolidated balance sheets in investments in unconsolidated entities, at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Dividend income, if any, received is reported in the consolidated statements of operations in equity in losses from unconsolidated entities.
If the fair value of an equity investment declines below its respective carrying amount and the decline is determined to be other‑than‑temporary, the investment will be written down to its fair value.
Use of Estimates —The preparation of unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include the preparation of the Company’s consolidated financial statements on the basis that the Company will continue as a going concern, the collectability of accounts receivable, inventory net realizable values, realization of deferred tax assets, valuation of stock-based compensation expense, the useful lives of property, plant and equipment and intangible assets, the recoverability of the carrying amount of property, plant and equipment, intangible assets and investments in unconsolidated entities, the fair value of acquired tangible and intangible assets, income tax uncertainties, provision for potential litigation costs and other contingencies. Management bases its estimates on historical experience and also on assumptions that it believes are reasonable. Management assesses these estimates on a regular basis; however, actual results could differ materially from those estimates.
Certain Significant Risks and Uncertainties —The Company is subject to certain risks and uncertainties that could have a material and adverse effect on the Company’s future financial position or results of operations, which risks and uncertainties include, among others: it has incurred significant losses over the past several years, any inability of the Company to compete in a rapidly evolving market and to respond quickly and effectively to changing market requirements, any inability of the Company to grow its revenue and/or maintain or increase its margins, it may experience fluctuations in its revenues and operating results, any inability of the Company to protect its intellectual property rights, claims by others that the Company infringes their proprietary technology, and any inability of the Company to raise additional funds in the future.
Concentration of Supply Risk —Some of the components and technologies used in the Company’s products are purchased and licensed from a limited number of sources and some of the Company’s products are produced by a limited number of contract manufacturers. The loss of any of these suppliers and contract manufacturers may cause the Company to incur transition costs to another supplier or contract manufacturer, result in delays in the manufacturing and delivery of the Company’s products, or cause it to carry excess or obsolete inventory. The Company relies on a limited number of such suppliers and contract manufacturers for the fulfillment of its customer orders. Any failure of such suppliers and contract manufacturers to perform could have an adverse effect upon the Company’s reputation and its ability to distribute its products or satisfy customers’ orders, which could adversely affect the Company’s business, financial position, results of operations and cash flows.
Concentration of Credit Risk —Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivable.
8
The Company keeps its cash and cash equivalents in demand deposits with prominent banks of high credit quality and invests only in money market funds. Deposits held with banks may exceed the amount of insurance provided on such deposits. As of November 30, 20 20 and August 31, 20 20 , cash and cash equivalents of the Company consisted of the following (in thousands):
November 30,
August 31,
Cash and Cash Equivalents by Location
2020
2020
United States;
Denominated in U.S. dollars
$
179
$
251
Taiwan;
Denominated in U.S. dollars
2,424
2,514
Denominated in New Taiwan dollars (NT$)
35
52
Denominated in other currencies
55
15
Total cash and cash equivalents
$
2,693
$
2,832
The Company’s revenues are substantially derived from the sales of LED products. A significant portion of the Company’s revenues are derived from a limited number of customers and sales are concentrated in a few select markets. Management performs ongoing credit evaluations of its customers and generally does not require collateral on accounts receivable. Management evaluates the need to establish an allowance for doubtful accounts for estimated potential credit losses at each reporting period. The allowance for doubtful accounts is based on the management’s assessment of the collectability of its customer accounts. Management regularly reviews the allowance by considering certain factors, such as historical experience, industry data, credit quality, ages of accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.
Net revenues generated from sales to the top ten customers represented 85% of the Company’s total net revenues for both the three months ended November 30, 2020 and 2019.
The Company’s revenues have been concentrated in a few select markets, including the Netherlands, Ireland, Taiwan, Japan, the United States, Germany and India. Net revenues generated from sales to customers in these markets, in the aggregate, accounted for 75% and 89% of the Company’s net revenues for the three months ended November 30, 2020 and 2019, respectively.
Noncontrolling Interests —Noncontrolling interests are classified in the consolidated statements of operations as part of consolidated net income (loss) and the accumulated amount of noncontrolling interests in the consolidated balance sheets as part of equity. Changes in ownership interest in a consolidated subsidiary that do not result in a loss of control are accounted for as an equity transaction. If a change in ownership of a consolidated subsidiary results in loss of control and deconsolidation, any retained ownership interests are remeasured with the gain or loss reported in net earnings. On September 1, 2018, Taiwan Bandaoti Zhaoming Co., Ltd., the Company’s wholly owned operating subsidiary, issued 414,000 common shares and amended its certificate of incorporation to increase its issued common stock from 12,087,715 to 12,501,715. As of the issuance date, the increased capital of $176 thousand (NT$5.4 million) has been completely received in cash by Taiwan Bandaoti Zhaoming Co., Ltd. The Company did not subscribe for the newly issued common shares, and, as a result, noncontrolling interest in the Company was increased from zero to 3.31%. From January 2019 to November 2020, the Company purchased an additional 33,000 shares of Taiwan Bandaoti Zhaoming Co., Ltd. from non-controlling shareholders. Therefore, noncontrolling interest in SBDI was down to 3.05% as of November 30, 2020.
Recent Accounting Pronouncements
In December 2019, the FASB issued ASU No. 2019-12, simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in accounting standards. The amendments in the ASU are effective for fiscal years beginning after December 15, 2020, including interim periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements have not yet been issued. The Company is currently evaluating the impact ASU 2019-12 will have on the disclosures included in its consolidated financial statements.
9
3. Balance Sheet Components
Inventories
Inventories as of November 30, 2020 and August 31, 2020 consisted of the following (in thousands):
November 30,
August 31,
2020
2020
Raw materials
$
383
$
433
Work in process
936
792
Finished goods
1,446
1,251
Total
$
2,765
$
2,476
Inventory write-downs to estimated net realizable values were $196 thousand and $119 thousand for the three months ended November 30, 2020 and 2019, respectively.
Property, Plant and Equipment
Property, plant and equipment as of November 30, 2020 and August 31, 2020 consisted of the following (in thousands):
November 30,
August 31,
2020
2020
Buildings and improvements
$
14,441
$
14,104
Machinery and equipment
34,520
33,977
Leasehold improvements
170
166
Other equipment
2,476
2,384
Construction in progress
9
7
Total property, plant and equipment
51,616
50,638
Less: Accumulated depreciation and amortization
(45,995
)
(44,993
)
Property, plant and equipment, net
$
5,621
$
5,645
Intangible Assets
Intangible assets as of November 30, 2020 and August 31, 2020 consisted of the following (in thousands):
November 30, 2020
Weighted
Average
Gross
Net
Amortization
Carrying
Accumulated
Carrying
Period (Years)
Amount
Amortization
Amount
Patents and trademarks
15
$
562
$
474
$
88
Acquired technology
5
353
353
—
Total
$
915
$
827
$
88
August 31, 2020
Weighted
Average
Gross
Net
Amortization
Carrying
Accumulated
Carrying
Period (Years)
Amount
Amortization
Amount
Patents and trademarks
15
$
550
$
461
$
89
Acquired technology
5
345
345
—
Total
$
895
$
806
$
89
10
4. Investments in Unconsolidated Entities
The Company’s ownership interest and carrying amounts of investments in unconsolidated entities as of November 30, 2020 and August 31, 2020 consisted of the following (in thousands, except percentages):
November 30, 2020
August 31, 2020
Percentage
Percentage
Ownership
Amount
Ownership
Amount
Equity investment without readily determinable fair value
Various
974
Various
952
Total investments in unconsolidated entities
$
974
$
952
There were no dividends received from unconsolidated entities through November 30, 2020.
Equity Investments without readily determinable fair value
Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the Company) which do not have readily determinable fair values are recorded as equity investment without readily determinable fair value. All equity investments without readily determinable fair value are assessed for impairment when events or changes in circumstances indicate that the carrying amounts may not be recoverable, and measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuers.
5. Assets and Liabilities held for sale
In November 2019, the Company entered into a stock purchase agreement to sell all of the outstanding shares of the Company’s Hong Kong Subsidiary, Semileds International Corporation Limited, and its wholly owned subsidiary Xuhe Guangdian Co Ltd. The Company closed the transaction in January 2020.
As of November 30, 2019, all the assets and liabilities relating to the Company’s Hong Kong Subsidiary were reported as assets and liabilities held-for-sale in the consolidated balance sheets.
The following is a summary of the major classes of assets and liabilities included as assets and liabilities held for sale as of November 30, 2019.
November 30, 2019
Assets
Cash and cash equivalents
$
61
Accounts receivable, net
263
Inventory
4
Prepaid expenses and other current assets
72
Other assets
1
$
401
Liabilities
Accounts payable
$
786
Accrued expenses and other current liabilities
4
Total
$
790
6. Commitments and Contingencies
Operating Lease Agreements —The Company has several operating leases with unrelated parties, primarily for land, plant and office spaces in Taiwan, which include cancellable and noncancellable leases and which expire at various dates between December 2020 and December 2029. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company did not combine lease and non-lease components.
Most leases do not include options to renew. The exercise of lease renewal options has to be agreed by the leasers. The depreciable life of assets and leasehold improvements are limited by the term of leases, unless there is a transfer of title or purchase option reasonably certain of exercise. Lease expense is recognized on a straight-line basis over the term of the leases. Lease expense
11
related to these noncancellable operating leases were $ 40 and $ 38 thousand for three months ended November 30, 20 20 and 201 9, respectively .
Balance sheet information related to the Company’s leases is presented below:
November 30, 2020
Assets
Operating lease right of use assets
$
168
Liabilities
Operating lease liabilities, current portion
$
77
Operating lease liabilities, less current portion
91
Total
$
168
The following provides details of the Company’s lease expenses:
Three Months Ended
November 30, 2020
Operating lease expenses, net
$
40
Other information related to leases is presented below:
Three Months Ended
November 30, 2020
Cash Paid for amounts Included In Measurement of Liabilities:
Operating cash flows from operating leases
$
40
Weighted Average Remaining Lease Term:
Operating leases
2.09 years
Weighted Average Discount Rate
Operating leases
1.76
%
As most of the Company’s leases do not provide an implicit rate, the Company uses its average borrowing rate from non-related parties of 1.76% based on the information available at commencement date in determining the present value of lease payments.
The aggregate future noncancellable minimum rental payments for the Company’s operating leases as of November 30, 2020 consisted of the following (in thousands):
Years Ending August 31,
Operating Leases
Remainder of 2021
$
62
2022
32
2023
12
2024
12
2025
12
Thereafter
52
Total future minimum lease payments, undiscounted
$
182
Less: Imputed interest
(14
)
Present value of future minimum lease payments
$
168
Purchase Obligations —The Company had purchase commitments for inventory, property, plant and equipment in the amount of $145 thousand and $33 thousand as of November 30, 2020 and August 31, 2020, respectively.
Litigation —The Company is directly or indirectly involved from time to time in various claims or legal proceedings arising in the ordinary course of business. The Company recognizes a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is significant judgment required in assessing both the likelihood of an unfavorable outcome and whether the amount of loss, if any, can be reasonably estimated. However, the Company cannot predict the outcome of any litigation or the potential for future litigation.
12
On June 21, 2017, Well Thrive Ltd. (“Well Thrive”) filed a complaint against SemiLEDs Corporation in the United States District Court for the District of Delaware. The complaint alleged that Well Thrive wa s entitled to the return of $ 500 thousand paid toward a note purchase pursuant to a purchase agreement (the “Purchase Agreement”) effective July 6, 2016 with Dr. Peter Chiou, which was assigned to Well Thrive on August 4, 2016. Pursuant to the terms of the Purchase Agreement, the Company retained the $500 thousand payment as liquidated damages. Well Thrive allege d that the liquidated damages provision wa s unenforceable as an illegal penalty and d id not reflect the amount of purported damages. On March 13, 2018, the Company filed a motion to enforce a settlement agreement between the parties to dismiss the lawsuit with prejudice. On March 27, 2018, Well Thrive filed an answering brief in opposition to the Company’s motion on the basis that Well Thrive never consented to dismiss the case. The judge’s order allowed the Company to conduct depositions of Well Thrive’s former lawyer, Dr. Chiou, and Mr. Chang Sheng-Chun, Well Thrive’s director, and to request documents relating to the issues surrounding the settlement. Based on this order, the Company arrange d the depositions to obtain more evidence in support of a motion to enforce the settlement agreement. The Court held a trial on March 2, 2020. After the trial, judge ordered both sides to prepare post-trial briefs and proposed findings of fact for the Court to be submitted before the end of April 2020. Both sides submitted post-tr ia l briefs and proposed findings of fact on April 30, 2020. On December 21, 2020, the judge, following a hearing, issued her judgment , which orders SemiLEDs to return the $ 500,000 to Well Thrive, and require d both parties, on or before January 6, 2021, to submit information on the appropriate amount of interest to be added. On January 6, 2021, the Company filed a brief arguing that there should not be an award of prejudgment interest and Well Thrive is arguing for the amount of $ 135,77 4 in pre-judgment interest. The Company recorded the $ 500,000 in Advance receipt toward the convertible note under current liabilities as of November 30, 2020.
Except as described above, as of November 30, 2020, there was no pending or threatened litigation that could have a material impact on the Company’s financial position, results of operations or cash flows.
7. Common Stock
On January 17, 2020, the Company entered into a definitive common stock purchase agreement with XianChang Ma. Pursuant to the terms of the Agreement, Mr. Ma purchased 150,000 shares of the Company’s common stock at $4.00 per share, representing approximately 4% of the outstanding shares of the Company at the time of purchase. The Company received the $600,000 purchase price in full on January 17, 2020.
On May 25, 2020, the Company entered into a definitive common stock purchase agreement (the “Agreement”) with FengShuang Zhu. Pursuant to the terms of the Agreement, Mr. Zhu purchased 33,333 shares of the Company’s common stock at $3.00 per share for an aggregate purchase price of $100,000. The Company received the $100,000 purchase price in full on May 25. 2020.
On May 25, 2020, J.R. Simplot Company, the largest shareholder of the Company, and Trung Doan, the Chairman and Chief Executive Officer of the Company, each converted $300,000 of convertible unsecured promissory notes into 100,000 shares of the Company’s common stock (see Note 11).
8. Stock-based Compensation
The Company currently has one equity incentive plan (the “2010 Plan”), which provides for awards in the form of restricted shares, stock units, stock options or stock appreciation rights to the Company’s employees, officers, directors and consultants. In April 2014, SemiLEDs’ stockholders approved an amendment to the 2010 Plan that increased the number of shares authorized for issuance under the plan by an additional 250 thousand shares. On July 31, 2019, the stockholders approved an increase in the authorized share reserve under the 2010 plan by an additional 500 thousand shares, to extend expiration of the 2010 Plan to November 3, 2023, to remove the IRS Code section 162(m) provisions, and to modify the maximum grant limit to 35 thousand shares to one person in a one year period. On September 25, 2020, stockholders approved the amended 2010 Equity Incentive Plan to increase the authorized shares reserve by an additional 400,000 shares.
Prior to SemiLEDs’ initial public offering, the Company had another stock‑based compensation plan (the “2005 Plan”), but awards are made from the 2010 Plan after the initial public offering. Options outstanding under the 2005 Plan continue to be governed by its existing terms.
A total of 1,421 and 1,021 thousand shares was reserved for issuance under and 2010 Plan as of November 30, 2020 and 2019, respectively. As of November 30, 2020 and 2019, there were 1,092 thousand and 684 thousand shares of common stock available for future issuance under the equity incentive plans.
In November 2020, SemiLEDs granted 15 thousand restricted stock units to its directors, which vest 25% every three months on February 12, 2021, May 12, 2021, August 12, 2021 and November 12, 2021. In the event that the 2021 annual meeting falls before
13
November 12, 2021, 100% of the stock units shall immediately vest on the date of the 2021 annual meeting. The grant-date fair value of the restricted stock units was $ 3.00 per unit.
In November 2020, SemiLEDs granted 33 thousand restricted stock units to its employees, which vest 25% every three months on February 12, 2021, May 12, 2021, August 12, 2021 and November 12, 2021 and will become fully vested upon a change in control. The grant-date fair value of the restricted stock units was $3.00 per unit.
In January 2020, SemiLEDs granted 136 thousand restricted stock units to its employees, which vest 25% each year on January 10 of 2021, 2022, 2023 and 2024 and will become fully vested upon a change in control. The grant-date fair value of the restricted stock units was $2.39 per unit.
In September 2019, SemiLEDs granted 5 thousand restricted stock units to its directors, which vested 100% on July 31, 2020. The grant-date fair value of the restricted stock units was $2.45 per unit.
In September 2019, SemiLEDs granted 2.5 thousand restricted stock units to a director, which vested 100% on September 5, 2020. The grant-date fair value of the restricted stock units was $2.45 per unit.
The grant date fair value of stock options is determined using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires inputs including the market price of SemiLEDs’ common stock on the date of grant, the term that the stock options are expected to be outstanding, the implied stock volatilities of several of the Company’s publicly-traded peers over the expected term of stock options, risk-free interest rate and expected dividend. Each of these inputs is subjective and generally requires significant judgment to determine. The grant date fair value of stock units is based upon the market price of SemiLEDs’ common stock on the date of the grant. This fair value is amortized to compensation expense over the vesting term.
Stock-based compensation expense is recorded net of estimated forfeitures such that expense is recorded only for those stock-based awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. A forfeiture rate of zero is estimated for stock-based awards with vesting term that is less than or equal to one year from the date of grant.
A summary of the stock-based compensation expense for the three months ended November 30, 2020 and 2019 was as follows (in thousands):
Three Months Ended November 30,
2020
2019
Cost of revenues
$
5
$
11
Research and development
4
6
Selling, general and administrative
12
18
$
21
$
35
9. Net Loss Per Share of Common Stock
The following stock-based compensation plan awards were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been anti-dilutive (in thousands of shares):
Three Months Ended November 30,
2020
2019
Stock units and stock options to purchase common stock
73
30
10. Income Taxes
The Company’s loss before income taxes for the three months ended November 30, 2020 and 2019 consisted of the following (in thousands):
Three Months Ended November 30,
2020
2019
U.S. operations
$
(137
)
$
(197
)
Foreign operations
(570
)
(125
)
Loss before income taxes
$
(707
)
$
(322
)
14
Unrecognized Tax Benefits
On December 22, 2017, the U.S. Tax Cuts and Jobs Act was adopted, which among other effects, reduced the U.S. federal corporate income tax rate to 21% from 34% (or 35% in certain cases) beginning in 2018, requires companies to pay a one-time transition tax on certain unrepatriated earnings from non-U.S. subsidiaries that is payable over eight years, makes the receipt of future non-U.S. sourced income of non-U.S. subsidiaries tax-free to U.S. companies and creates a new minimum tax on the earnings of non-U.S. subsidiaries relating to the parent’s deductions for payments to the subsidiaries. Provisional estimate of the Company is that no tax will be due under this provision.
As of both November 30, 2020 and August 31, 2020, the Company had no unrecognized tax benefits related to tax positions taken in prior periods. The Company files income tax returns in the United States, various U.S. states and certain foreign jurisdictions. The tax years 2016 through 2019 remain open in most jurisdictions. With few exceptions, as of November 30, 2020, the Company is no longer subject to U.S. federal, state, local, or foreign examinations by tax authorities for tax years before 2015. The Company is not currently under examination by income tax authorities in federal, state or foreign jurisdictions.
11. Related Party Transactions
On December 6, 2019 and on December 10, 2019, the Company issued convertible unsecured promissory notes (the “Notes”) to each of J.R. Simplot Company, its largest shareholder, and Trung Doan, its Chairman and Chief Executive Officer (together, the “Holders”), with a principal sum of $1.5 million and $500 thousand, respectively, and an annual interest rate of 3.5%. Principal and accrued interest shall be due on demand by the Holders on and at any time after May 30, 2021. The outstanding principal and unpaid accrued interest of the Notes may be converted into the Company’s common stock based on a conversion price of $3.00 per share, at the option of the Holders any time from the date of the Notes. On May 25, 2020, each of the Holders converted $300,000 of the Notes into 100,000 shares of the Company’s common stock.
On January 8, 2019, the Company entered into loan agreements with each of the Chairman and Chief Executive Officer and the largest shareholder of the Company, with aggregate amounts of $1.7 million and $1.5 million, respectively, and an annual interest rate of both 8%. All proceeds of the loans were exclusively used to return the deposit to Formosa Epitaxy Incorporation in connection with the cancelled proposed sale of the Company’s headquarters building pursuant to the agreement dated December 15, 2015. The Company is required to repay the loans of $1.5 million on January 14, 2021 and $1.7 million on January 22, 2021, respectively, unless the loans are sooner accelerated pursuant to the loan agreements. As of November 30, 2020 and August 31, 2020, these loans totaled $3.2 million. The loans are secured by a second priority security interest on the headquarters building of the Company.
12. Subsequent Events
On December 21, 2020, the judge, following a hearing, issued her judgment, which orders SemiLEDs to return $500,000 to Well Thrive Ltd., and required both parties, on or before January 6, 2021, to submit information on the appropriate amount of interest to be added. On January 6, 2021, the Company filed a brief arguing that there should not be an award of prejudgment interest and Well Thrive is arguing for the amount of $135,774 in pre-judgment interest. The $500,000 was paid toward a note purchase pursuant to a purchase agreement (see Note 6), and the Company recorded the $500,000 as ‘Advance receipt toward the convertible note’.
The Company has analyzed its operations subsequent to November 30, 2020 to the date these unaudited condensed consolidated financial statements were issued, finding that the impact of COVID-19 on the Company is unknown at this time and the financial consequences of this situation cause uncertainty as to the future and its effects on the economy and the Company.
Except for the above, the Company has determined that it does not have any other material subsequent events to disclose in these unaudited condensed consolidated financial statements.
15
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.